Dr Adrian H Chester

Publications


Journals

  • Sarathchandra P; Smolenski RT; Yuen AH; Chester AH; Goldstein S; Heacox AE; Yacoub MH; Taylor PM. (4 Nov 2011). Impact of γ-Irradiation on Extracellular Matrix of Porcine Pulmonary Valves. J Surg Res. DOI.
  • Lewinsohn AD; Anssari-Benham A; Lee DA; Taylor PM; Chester AH; Yacoub MH; Screen HRC. (2011). Anisotropic strain transfer through the aortic valve and its relevance to the cellular mechanical environment. P I MECH ENG H. 225:821-830. DOI.
  • Salhiyyah K; Yacoub MH; Chester AH. (Dec 2011). Cellular mechanisms in mitral valve disease. J Cardiovasc Transl Res. 4:702-709. DOI.
  • Miragoli M; Moshkov A; Novak P; Shevchuk A; Nikolaev VO; El-Hamamsy I; Potter CM; Wright P; et alKadir SH; Lyon AR; Mitchell JA; Chester AH; Klenerman D; Lab MJ; Korchev YE; Harding SE; Gorelik J. (6 Jul 2011). Scanning ion conductance microscopy: a convergent high-resolution technology for multi-parametric analysis of living cardiovascular cells. J R Soc Interface. 8:913-925. DOI.
  • Colazzo F; Sarathchandra P; Smolenski RT; Chester AH; Tseng YT; Czernuszka JT; Yacoub MH; Taylor PM. (Jan 2011). Extracellular matrix production by adipose-derived stem cells: implications for heart valve tissue engineering. Biomaterials. 32:119-127. DOI.
  • Colazzo F; Chester AH; Taylor PM; Yacoub MH. (Nov 2010). Induction of mesenchymal to endothelial transformation of adipose-derived stem cells. J Heart Valve Dis. 19:736-744.
  • Xu Y; Chester AH; Hariri B; McCormack A; Sarathchandra P; Rose ML. (15 Dec 2010). The indirect alloimmune response causes microvascular endothelial dysfunction-a possible role for alloantibody. Transplantation. 90:1157-1164. DOI.
  • Norris RA; Moreno-Rodriguez R; Wessels A; Merot J; Bruneval P; Chester AH; Yacoub MH; Hagège A; et alSlaugenhaupt SA; Aikawa E; Schott JJ; Lardeux A; Harris BS; Williams LK; Richards A; Levine RA; Markwald RR. (Jul 2010). Expression of the familial cardiac valvular dystrophy gene, filamin-A, during heart morphogenesis. Dev Dyn. 239:2118-2127. DOI.
  • Din S; Sarathchandra P; Yacoub MH; Chester AH. (Nov 2009). Interaction between bone morphogenetic proteins and endothelin-1 in human pulmonary artery smooth muscle. Vascul Pharmacol. 51:344-349. DOI.
  • El-Hamamsy I; Balachandran K; Yacoub MH; Stevens LM; Sarathchandra P; Taylor PM; Yoganathan AP; Chester AH. (21 Apr 2009). Endothelium-Dependent Regulation of the Mechanical Properties of Aortic Valve Cusps. J AM COLL CARDIOL. 53:1448-1455. DOI.
  • El-Hamamsy I; Yacoub MH; Chester AH. (Jan 2009). Neuronal regulation of aortic valve cusps. Curr Vasc Pharmacol. 7:40-46.
  • Mangoush O; Athanasiou T; Nakamura K; Johnson P; Smoienski R; Sarathchandra P; Oury T; Chester AH; et alAmrani M. (Feb 2008). Antioxidant properties of the internal thoracic artery and the radial artery. HEART LUNG CIRC. 17:40-47. DOI.
  • Chester AH; Kershaw JD; Sarathchandra P; Yacoub MH. (Jun 2008). Localisation and function of nerves in the aortic root. J Mol Cell Cardiol. 44:1045-1052. DOI.
  • Osman L; Chester AH; Sarathchandra P; Latif N; Meng WF; Taylor PM; Yacoub MH. (11 Sep 2007). A novel role of the sympatho-adrenergic system in regulating valve calcification. CIRCULATION. 116:I282-I287. DOI.
  • Smith S; Taylor PM; Chester AH; Allen SP; Dreger SA; Eastwood M; Yacoub MH. (Jul 2007). Force generation of different human cardiac valve interstitial cells: relevance to individual valve function and tissue engineering. J Heart Valve Dis. 16:440-446.
  • Allen SP; Chester AH; Dzimiri NF; Duran CM; Yacoub M. (Jul 1995). Vascular biology of human saphenous veins. Ann Saudi Med. 15:378-384.
  • Chester AH; Taylor PM. (29 Aug 2007). Molecular and functional characteristics of heart-valve interstitial cells. Philos Trans R Soc Lond B Biol Sci. 362:1437-1443. DOI.
  • Terrovitis JV; Bulte JW; Sarvananthan S; Crowe LA; Sarathchandra P; Batten P; Sachlos E; Chester AH; et alCzernuszka JT; Firmin DN; Taylor PM; Yacoub MH. (Oct 2006). Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells seeded on collagen scaffolds-relevance to tissue engineering. Tissue Eng. 12:2765-2775. DOI.
  • Latif N; Sarathchandra P; Thomas PS; Antoniw J; Batten P; Chester AH; Taylor PM; Yacoub MH. (Jan 2007). Characterization of structural and signaling molecules by human valve interstitial cells and comparison to human mesenchymal stem cells. J Heart Valve Dis. 16:56-66.
  • Kelsall CJ; Chester AH; Sarathchandra P; Singer DR. (Dec 2006). Expression and localization of C-type natriuretic peptide in human vascular smooth muscle cells. Vascul Pharmacol. 45:368-373. DOI.
  • Chester AH; Azam R; Felkin LE; George R; Brand N. (Mar 2007). Correlation between vascular responsivensss and expression of novel transcripts of the ETA-receptor in human vascular tissue. Vascul Pharmacol. 46:181-187. DOI.
  • Terrovitis JV; Bulte JW; Sarvananthan S; Crowe LA; Sarathchandra P; Batten P; Sachlos E; Chester AH; et alCzernuszka JT; Firmin DN; Taylor PM; Yacoub MH. (1 Sep 2006). Magnetic Resonance Imaging of Ferumoxide-Labeled Mesenchymal Stem Cells Seeded on Collagen Scaffolds-Relevance to Tissue Engineering. Tissue Eng. Publisher weblink DOI.
  • Dreger SA; Thomas P; Sachlos E; Chester AH; Czernuszka JT; Taylor PM; Yacoub MH. (Sep 2006). Potential for synthesis and degradation of extracellular matrix proteins by valve interstitial cells seeded onto collagen scaffolds. Tissue Eng. 12:2533-2540. DOI.
  • Dreger SA; Thomas P; Sachlos E; Chester AH; Czernuszka JT; Taylor PM; Yacoub MH. (1 Jul 2006). Potential for Synthesis and Degradation of Extracellular Matrix Proteins by Valve Interstitial Cells Seeded onto Collagen Scaffolds. Tissue Eng. Publisher weblink DOI.
  • Osman L; Yacoub MH; Latif N; Amrani M; Chester AH. (4 Jul 2006). Role of human valve interstitial cells in valve calcification and their response to atorvastatin. Circulation. 114:I547-I552. DOI.
  • Osman L; Chester AH; Amrani M; Yacoub MH; Smolenski RT. (4 Jul 2006). A novel role of extracellular nucleotides in valve calcification: a potential target for atorvastatin. Circulation. 114:I566-I572. DOI.
  • Bowen IM; Marr CM; Wheeler-Jones CPD; Chester AH; Elliott J. (May 2006). The effects of aging on the structure and function of the equine aortic valve. J VET INTERN MED. 20:742-742.
  • Ku CH; Johnson PH; Batten P; Sarathchandra P; Chambers RC; Taylor PM; Yacoub MH; Chester AH. (1 Aug 2006). Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch. Cardiovasc Res. 71:548-556. DOI.
  • Taylor PM; Sachlos E; Dreger SA; Chester AH; Czernuszka JT; Yacoub MH. (May 2006). Interaction of human valve interstitial cells with collagen matrices manufactured using rapid prototyping. Biomaterials. 27:2733-2737. DOI.
  • Kelsall CJ; Chester AH; Amrani M; Singer DR. (Oct 2005). C-type natriuretic peptide relaxes human coronary artery bypass grafts preconstricted by endothelin-1. Ann Thorac Surg. 80:1347-1351. DOI.
  • Chester AH. (Oct 2005). Endothelin-1 and the aortic valve. Curr Vasc Pharmacol. 3:353-357.
  • Borland JA; Kelsall C; Yacoub MH; Chester AH. (Feb 2005). Expression, localisation and function of ACE and chymase in normal and atherosclerotic human coronary arteries. Vascul Pharmacol. 42:99-108. DOI.
  • Nakamura K; Al-Ruzzeh S; Chester AH; Ilsley C; Yacoub MH; Amrani M. (Jan 2005). Differential effect of cerivastatin and L-arginine on the vascular function of human radial and left internal thoracic arteries. J Card Surg. 20:22-28. DOI.
  • Hafizi S; Wang X; Chester AH; Yacoub MH; Proud CG. (Sep 2004). ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells. Am J Physiol Heart Circ Physiol. 287:H1232-H1238. DOI.
  • Kershaw JD; Misfeld M; Sievers HH; Yacoub MH; Chester AH. (Sep 2004). Specific regional and directional contractile responses of aortic cusp tissue. J Heart Valve Dis. 13:798-803.
  • Bowen IM; Marr CM; Chester AH; Wheeler-Jones CPD; Elliott J. (Jul 2004). In-vitro contraction of the eauine aortic valve. J HEART VALVE DIS. 13:593-599.
  • Hafizi S; Chester AH; Yacoub MH. (Jun 2004). Differential response of human cardiac fibroblasts to angiotensin I and angiotensin II. Peptides. 25:1031-1033. DOI.
  • Hafizi S; Mordi VN; Andersson KM; Chester AH; Yacoub MH. (May 2004). Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling. Vascul Pharmacol. 41:167-176. DOI.
  • Mikhail GW; Prasad SK; Li W; Rogers P; Chester AH; Bayne S; Stephens D; Khan M; et alGibbs JS; Evans TW; Mitchell A; Yacoub MH; Gatzoulis MA. (Mar 2004). Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects. Eur Heart J. 25:431-436. DOI.
  • Hafizi S; Wharton J; Chester AH; Yacoub MH. (2004). Profibrotic effects of endothelin-1 via the ETA receptor in cultured human cardiac fibroblasts. Cell Physiol Biochem. 14:285-292. DOI.
  • Nakamura K; Al-Ruzzeh S; Chester AH; Ilsley C; Yacoub MH; Amrani M. (Dec 2003). Differential in vitro response of the human radial artery versus left internal thoracic artery to cerivastatin: implications to bypass grafting. Ann Thorac Surg. 76:2023-2028.
  • Nakamura K; Al-Ruzzeh S; Chester AH; Dewar A; Rothery S; Severs NJ; Yacoub MH; Amrani M. (Apr 2003). Age-related changes in the protective effect of chronic administration of L-arginine on post-ischemic recovery of endothelial function. Eur J Cardiothorac Surg. 23:626-632.
  • Goodwin AT; Khan MA; Chester AH; Amrani M; Yacoub MH. (Aug 2002). Up-regulation of endothelin-converting-enzyme mRNA expression following cardioplegic arrest. CLINICAL SCIENCE. 103:206S-209S.
  • Misfeld M; Chester AH; Sievers HH; Yacoub MH. (Jul 2002). Biological mechanisms influencing the function of the aortic root. J Card Surg. 17:363-368.
  • Misfeld M; Morrison K; Sievers HH; Yacoub MH; Chester AH. (Jul 2002). Localization of immunoreactive endothelin and characterization of its receptors in aortic cusps. JOURNAL OF HEART VALVE DISEASE. 11:472-477.
  • Chester AH. (Jul 2002). Mast cells feel the strain. Cardiovasc Res. 55:13-15.
  • Nakamura K; Al-Ruzzeh S; Chester AH; Schmidt I; Barbir M; Yacoub MH; Amrani M. (Jun 2002). Effects of cerivastatin on vascular function of human radial and left internal thoracic arteries. Ann Thorac Surg. 73:1860-1865.
  • Brand N; Azam R; Pate A; Yacoub MH; Chester AH. (Mar 2002). A bioinformatics analysis of the structure and expression of the A-type endothelin receptor (EDNRA) gene. BRIT J PHARMACOL. 135.
  • Al-Bustami MH; Amrani M; Chester AH; Ilsley CJ; Yacoub MH. (20 Feb 2002). In vivo early and mid-term flow-mediated endothelial function of the radial artery used as a coronary bypass graft. J Am Coll Cardiol. 39:573-577.
  • Hoare GS; Chester AH; Yacoub MH; Marczin N. (Jan 2002). Regulation of NF-kappaB and ICAM-1 expression in human airway epithelial cells. Int J Mol Med. 9:35-44.
  • Chester AH; Misfeld M; Sievers HH; Yacoub MH. (Nov 2001). Influence of 5-hydroxytryptamine on aortic valve competence in vitro. J Heart Valve Dis. 10:822-825.
  • Forrest MR; Chester AH; Royston D. (Feb 2001). The effects of diaspirin cross-linked hemoglobin on the tone of human saphenous vein. Anesth Analg. 92:324-328.
  • Borland JA; Chester AH; Rooker SJ; Wharton J; Davie N; Amrani M; Yacoub MH. (Dec 2000). Expression and function of angiotensin converting enzyme, chymase, and angiotensin II in the human radial artery and internal thoracic artery. Ann Thorac Surg. 70:2054-2063.
  • Borland JA; Chester AH; Yacoub MH. (Nov 2000). The renin angiotensin system in bypass graft surgery. Curr Opin Cardiol. 15:371-377.
  • Chester AH; Amrani M; Sproson CA; Yacoub MH. (Aug 2000). Interaction between thromboxane A2 and 5-hydroxytryptamine in the radial artery compared to the internal thoracic artery. Gen Pharmacol. 35:89-93.
  • Chester AH; Borland JA. (Jun 2000). Chymase-dependent angiotensin II formation in human blood vessels. J Hum Hypertens. 14:373-376.
  • Hafizi S; Taylor PM; Chester AH; Allen SP; Yacoub MH. (May 2000). Mitogenic and secretory responses of human valve interstitial cells to vasoactive agents. J Heart Valve Dis. 9:454-458.
  • Bundy RE; Marczin N; Chester AH; Yacoub M. (Apr 2000). A redox-based mechanism for nitric oxide-induced inhibition of DNA synthesis in human vascular smooth muscle cells. Br J Pharmacol. 129:1513-1521. DOI.
  • Chester AH; Misfeld M; Yacoub MH. (Mar 2000). Receptor-mediated contraction of aortic valve leaflets. JOURNAL OF HEART VALVE DISEASE. 9:250-254.
  • Bundy RE; Marczin N; Birks EF; Chester AH; Yacoub MH. (Feb 2000). Transplant atherosclerosis: role of phenotypic modulation of vascular smooth muscle by nitric oxide. Gen Pharmacol. 34:73-84.
  • Hafizi S; Mordi VN; Andersson KM; Chester AH. (2 Nov 1999). Effects and mechanisms of action of cyclosporine A, FK506 and rapamycin on human coronary smooth muscle cell proliferation. CIRCULATION. 100:599-599.
  • Chester AH; Amrani M; Sproson CA; Yacoub MH. (2 Nov 1999). Interaction between thromboxane A(2) and 5-HT receptors in the radial artery compared to the internal thoracic artery. CIRCULATION. 100:598-598.
  • Bundy R; Marczin N; Chester AH; Yacoub M. (Nov 1999). Differential regulation of DNA synthesis by nitric oxide and hydroxyurea in vascular smooth muscle cells. Am J Physiol. 277:H1799-H1807.
  • Hoare GS; Marczin N; Chester AH; Yacoub MH. (Nov 1999). Role of oxidant stress in cytokine-induced activation of NF-kappaB in human aortic smooth muscle cells. Am J Physiol. 277:H1975-H1984.
  • Hafizi S; Allen SP; Goodwin AT; Chester AH; Yacoub MH. (Oct 1999). Endothelin-1 stimulates proliferation of human coronary smooth muscle cells via the ET(A) receptor and is co-mitogenic with growth factors. Atherosclerosis. 146:351-359.
  • Hafizi S; Chester AH; Yacoub MH. (Jul 1999). Inhibition of human cardiac fibroblast mitogenesis by blockade of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Clin Exp Pharmacol Physiol. 26:511-513.
  • Pate MA; Chester AH; Crabbe DS; Amrani M; Brown TJ; Roach AG; Yacoub MH. (Apr 1999). Characterisation of constrictor endothelin receptors in the human internal thoracic artery and saphenous vein. J Cardiovasc Pharmacol. 33:567-572.
  • Bundy RE; Marczin N; Morrison K; Chester AH; Yacoub M. (Mar 1999). Influence of nitric oxide (NO) on relaxation, cell cycle and apoptosis in human vascular smooth muscle cells (HVSMC). AM J RESP CRIT CARE. 159:A345-A345.
  • Hafizi S; Wharton J; Morgan K; Allen SP; Chester AH; Catravas JD; Polak JM; Yacoub MH. (8 Dec 1998). Expression of functional angiotensin-converting enzyme and AT1 receptors in cultured human cardiac fibroblasts. Circulation. 98:2553-2559.
  • Chester AH; Marchbank AJ; Borland JA; Yacoub MH; Taggart DP. (Dec 1998). Comparison of the morphologic and vascular reactivity of the proximal and distal radial artery. Ann Thorac Surg. 66:1972-1976.
  • Chester AH; Birks EJ; Yacoub MH. (Dec 1998). Role of nitric oxide following cardiac transplantation. J Hum Hypertens. 12:833-837.
  • Chester AH; Amrani M; Borland JA. (Nov 1998). Vascular biology of the radial artery. Curr Opin Cardiol. 13:447-452.
  • Hafizi S; Wharton J; Chester AH; Polak JM; Yacoub MH. (27 Oct 1998). Endothelin-1 stimulates collagen synthesis in cultured human cardiac fibroblasts via the ETA receptor. CIRCULATION. 98:179-179.
  • Pate A; Rooker SJ; Chester AH. (27 Oct 1998). Evidence for alternative splicing of the ETA receptor in human saphenous vein. CIRCULATION. 98:33-34.
  • Hafizi S; Taylor PM; Roy A; Allen SP; Chester AH; Yacoub MH. (27 Oct 1998). Evidence for profibrotic effects of angiotensin II and 5-hydroxytryptamine on cultured human valvular interstitial cells. CIRCULATION. 98:699-699.
  • Borland JAA; Amrani M; Wharton J; Catravas JD; Chester AH. (27 Oct 1998). Localisation and function of the renin angiotensin system in the human radial artery versus the internal thoracic artery. CIRCULATION. 98:606-606.
  • Borland JA; Chester AH; Morrison KA; Yacoub MH. (Oct 1998). Alternative pathways of angiotensin II production in the human saphenous vein. Br J Pharmacol. 125:423-428. DOI.
  • Hafizi S; Nobin R; Allen SP; Chester AH; Yacoub MH. (Oct 1998). Contrasting effects of platelet-derived growth factor (PDGF) isomers on mitogenesis, contraction and intracellular calcium concentration in human vascular smooth muscle. Acta Physiol Scand. 164:191-199.
  • Borland JA; Chester AH; Crabbe S; Parkerson JB; Catravas JD; Yacoub MH. (Aug 1998). Differential action of angiotensin II and activity of angiotensin-converting enzyme in human bypass grafts. J Thorac Cardiovasc Surg. 116:206-212.
  • Mikhail G; Chester AH; Gibbs JSR; Borland JAA; Banner NR; Yacoub MH. (15 Jul 1998). Role of vasoactive mediators in primary and secondary pulmonary hypertension. AM J CARDIOL. 82:254-+.
  • Mikhail G; Chester AH; Gibbs JS; Borland JA; Banner NR; Yacoub MH. (15 Jul 1998). Role of vasoactive mediators in primary and secondary pulmonary hypertension. Am J Cardiol. 82:254-255.
  • Borland JAA; Chester AH; Patterson JB; Catravas JD; Yacoub MH. (Jun 1998). Angiotensin converting enzyme activity and AT(1) receptor function in human blood vessels. J HYPERTENS. 16:S73-S73.
  • Hafizi S; Wharton J; Chester AH; Polak JM; Yacoub MH. (Jun 1998). Differential response of cultured human cardiac fibroblasts to angiotensin I and angiotensin II. J HYPERTENS. 16:S67-S67.
  • Chester AH; Morrison KJ; Yacoub MH. (Jun 1998). Expression of vascular adhesion molecules in saphenous vein coronary bypass grafts. Ann Thorac Surg. 65:1685-1689.
  • Chester AH; Borland JA; Buttery LD; Mitchell JA; Cunningham DA; Hafizi S; Hoare GS; Springall DR; et alPolak JM; Yacoub MH. (Jun 1998). Induction of nitric oxide synthase in human vascular smooth muscle: interactions between proinflammatory cytokines. Cardiovasc Res. 38:814-821.
  • Chester AH; Borland JA; Morrison KJ; Amrani M; Thom SM; Yacoub MH. (May 1998). Reactivity of small intramyocardial arteries from atherosclerotic and non-atherosclerotic human hearts. J Vasc Res. 35:170-178.
  • Bundy RE; Marczin N; Chester AH; Yacoub M. (20 Mar 1998). Redox regulation of S-nitrosoglutathione (GSNO)-induced inhibition of S phase progression in human aortic smooth muscle cells (HASM). FASEB J. 12:A948-A948.
  • Hafizi S; Chester AH; Allen SP; Morgan K; Yacoub MH. (1998). Growth response of human coronary smooth muscle cells to angiotensin II and influence of angiotensin AT1 receptor blockade. Coron Artery Dis. 9:167-175.
  • Chester AH; Buttery LD; Borland JA; Springall DR; Rothery S; Severs NJ; Polak JM; Yacoub MH. (1998). Structural, biochemical and functional effects of distending pressure in the human saphenous vein: implications for bypass grafting. Coron Artery Dis. 9:143-151.
  • Luu TN; Dashwood MR; Tadjkarimi S; Chester AH; Yacoub MH. (Nov 1997). ATP-sensitive potassium channels mediate vasodilatation produced by calcitonin gene-related peptide in human internal mammary but not gastroepiploic arteries. Eur J Clin Invest. 27:960-966.
  • Hafizi S; Chester AH; Yacoub MH. (Nov 1997). Molecular mechanisms of vascular smooth muscle cell growth. Curr Opin Cardiol. 12:495-503.
  • O'Regan DJ; Borland JA; Chester AH; Pennell DJ; Yacoub M; Pepper JR. (Sep 1997). Assessment of human long saphenous vein function with minimally invasive harvesting with the Mayo stripper. Eur J Cardiothorac Surg. 12:428-435.
  • Hafizi S; Goodwin AT; Chester AH; Yacoub MH. (15 Oct 1996). Endothelin-1 is a potent co-mitogen for cultured human coronary artery smooth muscle cells: Synergy with growth factors. CIRCULATION. 94:1391-1391.
  • Borland JA; Chester AH; Yacoub MH. (15 Oct 1996). Enhanced vasoreactivity of the human saphenous vein to angiotensin I and II: Implications for its performance as a bypass graft. CIRCULATION. 94:226-226.
  • Crabbe S; Borland JAA; Catravas JD; Chester AH; Yacoub MH. (15 Oct 1996). Tissue angiotensin converting enzyme and its inhibition in human coronary artery bypass grafts. CIRCULATION. 94:223-223.
  • Buttery LD; Springall DR; Chester AH; Evans TJ; Standfield EN; Parums DV; Yacoub MH; Polak JM. (Jul 1996). Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 75:77-85.
  • Buttery LD; Chester AH; Springall DR; Borland JA; Michel T; Yacoub MH; Polak JM. (Jun 1996). Explanted vein grafts with an intact endothelium demonstrate reduced focal expression of endothelial nitric oxide synthase specific to atherosclerotic sites. J Pathol. 179:197-203. DOI.
  • Amrani M; Chester AH; Jayakumar J; Yacoub MH. (Jan 1996). Aging reduces postischemic recovery of coronary endothelial function. J Thorac Cardiovasc Surg. 111:238-245.
  • Chester AH; Borland JA; Taylor PM; Rose ML; Yacoub MH. (1996). Vascular adhesion molecules and immunogenicity in blood vessels used as coronary artery bypass grafts. Eur J Cardiothorac Surg. 10:676-683.
  • MIKHAIL GW; GIBBS JS; RICHARDSON M; CHESTER AH; ROGERS P; WRIGHT G; KHAGHANI A; BANNER NR; et alYACOUB MH. (15 Oct 1995). THE SUPERIORITY OF NEBULIZED PROSTACYCLIN IN THE TREATMENT OF PATIENTS WITH PRIMARY AND SECONDARY PULMONARY-HYPERTENSION. CIRCULATION. 92:1153-1153.
  • Amrani M; Chester AH; Jayakumar J; Schyns CJ; Yacoub MH. (Aug 1995). L-arginine reverses low coronary reflow and enhances postischaemic recovery of cardiac mechanical function. Cardiovasc Res. 30:200-204.
  • Chester AH; Jiang C; Borland JA; Yacoub MH; Collins P. (May 1995). Oestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms. Coron Artery Dis. 6:417-422.
  • Chester AH; Panda R; Borland JA; Tadjkarimi S; Schyns CJ; O'Neil GS; Yacoub MH. (Apr 1994). Effect of mode of application of papaverine on the contractile response of the internal mammary artery. Br J Surg. 81:527-531.
  • O'Neil GS; Chester AH; Schyns CJ; Tadjkarimi S; Borland JA; Yacoub MH. (Mar 1994). Effect of surgical preparation and arterialization on vasomotion of human saphenous vein. J Thorac Cardiovasc Surg. 107:699-706.
  • Tadjkarimi S; O'Neil GS; Schyns CJ; Borland JA; Chester AH; Yacoub MH. (Nov 1993). Vasoconstrictor profile of the inferior epigastric artery. Ann Thorac Surg. 56:1090-1095.
  • Allen SP; Sampson AP; Piper PJ; Chester AH; Ohri SK; Yacoub MH. (Oct 1993). Enhanced excretion of urinary leukotriene E4 in coronary artery disease and after coronary artery bypass surgery. Coron Artery Dis. 4:899-904.
  • Allen SP; Dashwood MR; Chester AH; Tadjkarimi S; Collins M; Piper PJ; Yacoub MH. (Mar 1993). Influence of atherosclerosis on the vascular reactivity of isolated human epicardial coronary arteries to leukotriene C4. Cardioscience. 4:47-54.
  • Chester AH; Allen SP; Tadjkarimi S; Yacoub MH. (Mar 1993). Interaction between thromboxane A2 and 5-hydroxytryptamine receptor subtypes in human coronary arteries. Circulation. 87:874-880.
  • Luu TN; Chester AH; O'Neil GS; Tadjkarimi S; Pepper JR; Yacoub MH. (Feb 1993). Different responses of the human gastroepiploic and internal mammary arteries to vasoactive peptides. Am J Physiol. 264:H583-H587.
  • Chester AH; O'Neil GS; Tadjakarimi S; Borland JA; Yacoub MH. (1993). Effect of peri-operative storage solution on the vascular reactivity of the human saphenous vein. Eur J Cardiothorac Surg. 7:399-404.
  • Allen SP; Chester AH; Piper PJ; Sampson AP; Akl ES; Yacoub MH. (Nov 1992). Effects of leukotrienes C4 and D4 on human isolated saphenous veins. Br J Clin Pharmacol. 34:409-414.
  • Mankad PS; Chester AH; Yacoub MH. (Jul 1992). Ischaemic endothelial dysfunction after single or multidose cardioplegia. Eur Heart J. 13:976-980.
  • Luu TN; Chester AH; O'Neil GS; Tadjkarimi S; Yacoub MH. (Jun 1992). Effects of vasoactive neuropeptides on human saphenous vein. Br Heart J. 67:474-477.
  • Tadjkarimi S; O'Neil GS; Luu TN; Allen SP; Schyns CJ; Chester AH; Yacoub MH. (Mar 1992). Comparison of cyclic GMP in human internal mammary artery and saphenous vein: implications for coronary artery bypass graft patency. Cardiovasc Res. 26:297-300.
  • Chester AH; O'Neil GS; Allen SP; Luu TN; Tadjkarimi S; Yacoub MH. (Mar 1992). Effect of endothelin on normal and diseased human coronary arteries. Eur J Clin Invest. 22:210-213.
  • O'Neil GS; Chester AH; Schyns CJ; Tadjkarimi S; Pepper JR; Yacoub MH. (Dec 1991). Vascular reactivity of human internal mammary and gastroepiploic arteries. Ann Thorac Surg. 52:1310-1314.
  • O'Neil GS; Chester AH; Allen SP; Luu TN; Tadjkarimi S; Ridley P; Khagani A; Musumeci F; et alYacoub MH. (Oct 1991). Endothelial function of human gastroepiploic artery. Implications for its use as a bypass graft. J Thorac Cardiovasc Surg. 102:561-565.
  • O'Neil GS; Chester AH; Kushwaha S; Rose M; Tadjkarimi S; Yacoub MH. (Sep 1991). Cyclosporin treatment does not impair the release of nitric oxide in human coronary arteries. Br Heart J. 66:212-216.
  • Mankad PS; Chester AH; Yacoub MH. (Mar 1991). 5-Hydroxytryptamine mediates endothelium dependent coronary vasodilatation in the isolated rat heart by the release of nitric oxide. Cardiovasc Res. 25:244-248.
  • Mankad PS; Chester AH; Yacoub MH. (Jan 1991). Role of potassium concentration in cardioplegic solutions in mediating endothelial damage. Ann Thorac Surg. 51:89-93.
  • Chester AH; Yacoub M. (Dec 1990). Vascular reactivity and endothelial function of bypass grafts. Curr Opin Cardiol. 5:733-736.
  • Chester AH; Martin GR; Bodelsson M; Arneklo-Nobin B; Tadjkarimi S; Tornebrandt K; Yacoub MH. (Nov 1990). 5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries. Cardiovasc Res. 24:932-937.
  • Chester AH; O'Neil GS; Moncada S; Tadjkarimi S; Yacoub MH. (13 Oct 1990). Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet. 336:897-900.
  • Chester AH; Dashwood MR; Clarke JG; Larkin SW; Davies GJ; Tadjkarimi S; Maseri A; Yacoub MH. (1 Jun 1989). Influence of endothelin on human coronary arteries and localization of its binding sites. Am J Cardiol. 63:1395-1398.

Conferences

  • New SEP; Chester AH; Sharma S; Safinia L; Cass AEG; Schaffer MSP; Yacoub MH; Taylor PM. The effect of carbon nanotubes on mesenchymal stem cells in a 3D environment. Annual Tissue-Engineering-and-Regenerative-Medicine-International-Society-European-Chapter Meeting. 14:912-912. (May 2008).
  • Osman L; Chester AH; Sarathchandra P; Latif N; Meng WF; Taylor PM; Yacoub MH. A novel role of the sympatho-adrenergic system in regulating valve calcification. 79th Annual Scientific Session of the American-Heart-Association. 116:I282-I287. (11 Sep 2007).
  • Dreger SA; Chester AH; Bowles CT; Yacoub MH; Taylor PM. Modification of biological scaffolds with specific extracellular matrix proteins enhances collagen synthesis by mesenchymal stem cells. Conference of the Tissue-Engineering-and-Regenerative-Medicine-International-Society (TERMIS-EU). 13:1729-1729. (Jul 2007).
  • New SEP; Chester AH; Yacoub MH; Taylor PM. Glycosaminoglycan synthesis by mesenchymal stem cells in response to stretch. Conference of the Tissue-Engineering-and-Regenerative-Medicine-International-Society (TERMIS-EU). 13:1702-1702. (Jul 2007).
  • Dreger SA; Taylor PM; Yacoub MH; Chester AH. Effect of alpha 2, alpha 5 and alpha nu beta 3 integrins on mesenchymal stem cell adhesion to extracellular matrix proteins. Conference of the Tissue-Engineering-and-Regenerative-Medicine-International-Society (TERMIS-EU). 13:1677-1678. (Jul 2007).
  • Bowles CT; Van Loon R; Dreger SA; Biglino G; Chan C; Parker KH; Chester AH; Taylor PM; et alYacoub MH. Hydrodynamic evaluation of a bioreactor for tissueengineering heart valves. 13:1708-1708. (Jul 2007).
  • Chester AH; Azam R; Felkin L; Brand NJ. Functional consequences for alternative splicing of the endothelin a receptor gene. 76th Annual Scientific Session of the American-Heart-Association. 108:20-20. (28 Oct 2003).
  • Din S; Chester AH. Bone morphogenetic protein-7 inhibits the release of endothelin-1 from human pulmonary smooth muscle cells. 77th Scientific Meeting of the American-Heart-Association. 110:333-333. (26 Oct 2004).
  • Osman L; Latif N; Ilsley C; Amrani M; Yacoub M; Chester AH. Atorvastatin inhibits the expression of valve calcification markers in human valve interstitial cells. 78th Annual Scientific Session of the American-Heart-Association. 112:U778-U778. (25 Oct 2005).
  • Osman L; Chester AH; Ilsley C; Amrani M; Smolenski R. Effect of atorvastatin on extracellular nucleotide degradation in valve interstitial cells: Implications for valve calcification. 78th Annual Scientific Session of the American-Heart-Association. 112:U778-U778. (25 Oct 2005).
  • Osman L; Smolenski RT; Latif N; Taylor PM; Amrani M; Yacoub MH; Chester AH. Protective mechanisms of atorvastatin in preventing heart valve calcification. 28th Annual International-Society-for-Heart-Research North American Section Meeting. 40:1014-1015. (Jun 2006).
  • Osman L; Latif N; Kelsall C; Taylor PM; Yacoub MH; Chester AH. Wnt3a modulates human valve interstitial cell growth and phenotype: Relevance to valve calcification. 79th Annual Scientific Session of the American-Heart-Association. 114:753-753. (31 Oct 2006).
  • Osman L; Smolenski RT; Latif N; Taylor PM; Amrani M; Yacoub MH; Chester AH. Further investigation of the cellular and molecular mechanisms of valve calcification. World Congress of Cardiology. 27:735-735. (Aug 2006).
  • Latif N; Sarathchandra P; Antoniw J; Taylor PM; Chester AH; Yacoub MH. Multiple differentiation potential of human valve interstitial cells. World Congress of Cardiology. 27:574-574. (Aug 2006).
  • Clark LA; Taylor PM; Brand N; Yacoub MH; Chester AH. Stimulation of collagen synthesis from cardiac fibroblasts by clenbuterol. World Congress of Cardiology. 27:268-268. (Aug 2006).
  • Osman L; Chester AH; Taylor PM; Magdi YH. A novel role of the sympatho-adrenergic system in regulating valve calcification. 114:792-792. (31 Oct 2006).
  • Batten P; Antoniw JW; Sarathchandra P; Chester AH; Taylor PM; Yacoub MH. Constitutive expression of heme oxygenase-1 (HO-1) in mesenchymal stem cells and its role in immunomodulation: relevance to tissue engineering heart valves. 27:735-735. (Aug 2006).
  • Clark LA; Taylor PM; Brand N; Yacoub MH; Chester AH. Stimulation of growth and collagen secretion in cardiac fibroblasts by clenbuterol. 40:947-947. (Jun 2006). DOI.
  • Brand NJ; Barton PJR; Felkin LE; Clark LA; Chester AH; Soppa GK; Terracciano CMN; Lara-Pezzi E; et alYacoub MH. Igf-1 transcription in cardiac myocytes and fibroblasts: Relevance to heart failure. 92. (Feb 2006).
  • Din S; Sarathchandra P; Yacoub MH; Chester AH. A possible role for endothelial to mesenchymal cell transformation in structural remodeling in pulmonary hypertension. 112:U370-U370. (25 Oct 2005).
  • Chester AH; Kershaw JD; Sarathchandra P; Yacoub MH. Inhibition of neuronal derived nitric oxide unmasks contractile responses of aortic valve cusps. 112:U138-U138. (25 Oct 2005).
  • Din S; Chester AH; Wall C; Yacoub MH. Inhibitory action of bonemorphogenetic protein 7 on endothelin induced contraction of human pulmonary arteries. 108:68-68. (28 Oct 2003).
  • Azam R; Felkin L; Brand NJ; Chester AH. Functional consequences for alternative splicing of the ETA receptor gene. 56:244-244. (Aug 2003).
  • Bowen IM; Marr CM; Chester AH; Elliott J. Characterisation of the contractile properties of an equine aortic valve preparation. 138:U73-U73. (Apr 2003).
  • Mikhail GW; Prasad S; Rogers P; Chester AH; Gibbs JSR; Evans T; Mitchell A; Yacoub MH; et alGatzoulis MA. Clinical and haemodynamic effects of sildenafil in pulmonary arterial hypertension. 106:340-340. (5 Nov 2002).
Share this on DeliciousTweet thisDigg thisStumble thisShare this on Facebook